The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma

Shinji Iizuka, Christopher Abdullah, Matthew D. Buschman, Begoña Diaz, Sara Courtneidge

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Metastatic cancer cells are characterized by their ability to degrade and invade through extracellular matrix. We previously showed that the Tks adaptor proteins, Tks4 and Tks5, are required for invadopodia formation and/or function in Srctransformed fibroblasts and a number of human cancer cell types. In this study, we investigated the role of Tks adaptor proteins in melanoma cell invasion and metastasis. Knockdown of either Tks4 or Tks5 in both mouse and human melanoma cell lines resulted in a decreased ability to form invadopodia and degrade extracellular matrix. In addition, Tks-knockdown melanoma cells had decreased proliferation in a 3-dimensional type l collagen matrix, but not in 2-dimensional culture conditions. We also investigated the role of Tks proteins in melanoma progression in vivo using xenografts and experimental metastasis assays. Consistent with our in vitro results, reduction of Tks proteins markedly reduced subcutaneous melanoma growth as well as metastatic growth in the lung. We explored the clinical relevance of Tks protein expression in human melanoma specimens using a tissue microarray. Compared to non-malignant nevi, both Tks proteins were highly expressed in melanoma tissues. Moreover, metastatic melanoma cases showed higher expression of Tks5 than primary melanoma cases. Taken together, these findings suggest the importance of Tks adaptor proteins in melanoma growth and metastasis in vivo, likely via functional invadopodia formation.

Original languageEnglish (US)
Pages (from-to)78473-78486
Number of pages14
JournalOncotarget
Volume7
Issue number48
DOIs
StatePublished - 2016

Fingerprint

Melanoma
Neoplasm Metastasis
Growth
Proteins
Extracellular Matrix
Podosomes
Nevus
Heterografts
Neoplasms
Collagen
Fibroblasts
Cell Line
Lung

Keywords

  • Invadopodia
  • Melanoma
  • MT1-MMP
  • Tks4
  • Tks5

ASJC Scopus subject areas

  • Oncology

Cite this

The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. / Iizuka, Shinji; Abdullah, Christopher; Buschman, Matthew D.; Diaz, Begoña; Courtneidge, Sara.

In: Oncotarget, Vol. 7, No. 48, 2016, p. 78473-78486.

Research output: Contribution to journalArticle

Iizuka, Shinji ; Abdullah, Christopher ; Buschman, Matthew D. ; Diaz, Begoña ; Courtneidge, Sara. / The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. In: Oncotarget. 2016 ; Vol. 7, No. 48. pp. 78473-78486.
@article{25c3d92ce65940f7903ac9d071ce81c4,
title = "The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma",
abstract = "Metastatic cancer cells are characterized by their ability to degrade and invade through extracellular matrix. We previously showed that the Tks adaptor proteins, Tks4 and Tks5, are required for invadopodia formation and/or function in Srctransformed fibroblasts and a number of human cancer cell types. In this study, we investigated the role of Tks adaptor proteins in melanoma cell invasion and metastasis. Knockdown of either Tks4 or Tks5 in both mouse and human melanoma cell lines resulted in a decreased ability to form invadopodia and degrade extracellular matrix. In addition, Tks-knockdown melanoma cells had decreased proliferation in a 3-dimensional type l collagen matrix, but not in 2-dimensional culture conditions. We also investigated the role of Tks proteins in melanoma progression in vivo using xenografts and experimental metastasis assays. Consistent with our in vitro results, reduction of Tks proteins markedly reduced subcutaneous melanoma growth as well as metastatic growth in the lung. We explored the clinical relevance of Tks protein expression in human melanoma specimens using a tissue microarray. Compared to non-malignant nevi, both Tks proteins were highly expressed in melanoma tissues. Moreover, metastatic melanoma cases showed higher expression of Tks5 than primary melanoma cases. Taken together, these findings suggest the importance of Tks adaptor proteins in melanoma growth and metastasis in vivo, likely via functional invadopodia formation.",
keywords = "Invadopodia, Melanoma, MT1-MMP, Tks4, Tks5",
author = "Shinji Iizuka and Christopher Abdullah and Buschman, {Matthew D.} and Bego{\~n}a Diaz and Sara Courtneidge",
year = "2016",
doi = "10.18632/oncotarget.12954",
language = "English (US)",
volume = "7",
pages = "78473--78486",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "48",

}

TY - JOUR

T1 - The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma

AU - Iizuka, Shinji

AU - Abdullah, Christopher

AU - Buschman, Matthew D.

AU - Diaz, Begoña

AU - Courtneidge, Sara

PY - 2016

Y1 - 2016

N2 - Metastatic cancer cells are characterized by their ability to degrade and invade through extracellular matrix. We previously showed that the Tks adaptor proteins, Tks4 and Tks5, are required for invadopodia formation and/or function in Srctransformed fibroblasts and a number of human cancer cell types. In this study, we investigated the role of Tks adaptor proteins in melanoma cell invasion and metastasis. Knockdown of either Tks4 or Tks5 in both mouse and human melanoma cell lines resulted in a decreased ability to form invadopodia and degrade extracellular matrix. In addition, Tks-knockdown melanoma cells had decreased proliferation in a 3-dimensional type l collagen matrix, but not in 2-dimensional culture conditions. We also investigated the role of Tks proteins in melanoma progression in vivo using xenografts and experimental metastasis assays. Consistent with our in vitro results, reduction of Tks proteins markedly reduced subcutaneous melanoma growth as well as metastatic growth in the lung. We explored the clinical relevance of Tks protein expression in human melanoma specimens using a tissue microarray. Compared to non-malignant nevi, both Tks proteins were highly expressed in melanoma tissues. Moreover, metastatic melanoma cases showed higher expression of Tks5 than primary melanoma cases. Taken together, these findings suggest the importance of Tks adaptor proteins in melanoma growth and metastasis in vivo, likely via functional invadopodia formation.

AB - Metastatic cancer cells are characterized by their ability to degrade and invade through extracellular matrix. We previously showed that the Tks adaptor proteins, Tks4 and Tks5, are required for invadopodia formation and/or function in Srctransformed fibroblasts and a number of human cancer cell types. In this study, we investigated the role of Tks adaptor proteins in melanoma cell invasion and metastasis. Knockdown of either Tks4 or Tks5 in both mouse and human melanoma cell lines resulted in a decreased ability to form invadopodia and degrade extracellular matrix. In addition, Tks-knockdown melanoma cells had decreased proliferation in a 3-dimensional type l collagen matrix, but not in 2-dimensional culture conditions. We also investigated the role of Tks proteins in melanoma progression in vivo using xenografts and experimental metastasis assays. Consistent with our in vitro results, reduction of Tks proteins markedly reduced subcutaneous melanoma growth as well as metastatic growth in the lung. We explored the clinical relevance of Tks protein expression in human melanoma specimens using a tissue microarray. Compared to non-malignant nevi, both Tks proteins were highly expressed in melanoma tissues. Moreover, metastatic melanoma cases showed higher expression of Tks5 than primary melanoma cases. Taken together, these findings suggest the importance of Tks adaptor proteins in melanoma growth and metastasis in vivo, likely via functional invadopodia formation.

KW - Invadopodia

KW - Melanoma

KW - MT1-MMP

KW - Tks4

KW - Tks5

UR - http://www.scopus.com/inward/record.url?scp=84998962538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998962538&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.12954

DO - 10.18632/oncotarget.12954

M3 - Article

C2 - 27802184

AN - SCOPUS:84998962538

VL - 7

SP - 78473

EP - 78486

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 48

ER -